EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study
NCT04265235 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2020-07-08
Summary
A prospective, single centre, single-arm, pilot study investigating the safety and efficacy of a 12-week remotely-monitored home-based exercise program in patients with refractory fatigue (based on PBC-40 Quality of Life measure) secondary to Primary Biliary Cirrhosis.
Conditions
Interventions
- OTHER
-
Home-based exercise program
see 'arm' section
Sponsors & Collaborators
-
University Hospital Birmingham NHS Foundation Trust
collaborator OTHER -
Intercept Pharmaceuticals
collaborator INDUSTRY -
University of Birmingham
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-07
- Primary Completion
- 2020-03-30
- Completion
- 2020-07-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Use of EL-FIT App to Promote Physical Activity
NCT04604860 ·Status: COMPLETED ·Phase: NA
-
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
NCT02308111 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH
NCT06675929 ·Status: COMPLETED ·Phase: PHASE2
-
IBAT Inhibitor A4250 for Cholestatic Pruritus
NCT02360852 ·Status: TERMINATED ·Phase: PHASE2
-
A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05293938 ·Status: WITHDRAWN
-
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
NCT02932449 ·Status: COMPLETED
-
Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05292872 ·Status: COMPLETED
-
Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
NCT01688024 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients
NCT02516605 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
NCT04267393 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
NCT01899703 ·Status: COMPLETED ·Phase: PHASE2
-
High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
NCT01603199 ·Status: COMPLETED ·Phase: NA
-
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
NCT06195943 ·Status: COMPLETED ·Phase: NA
-
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
NCT02273362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
NCT00550862 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
NCT03420768 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.
NCT03776175 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
NCT01389973 ·Status: COMPLETED ·Phase: PHASE2
-
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
NCT02400216 ·Status: COMPLETED
-
Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation
NCT03468140 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction
NCT07304843 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease
NCT04766476 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
NCT07325526 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases
NCT04420637 ·Status: COMPLETED
-
Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
NCT04650243 ·Status: RECRUITING ·Phase: PHASE4